The NSY mouse: a new animal model of spontaneous NIDDM with moderate obesity H. UedaH. IkegamiT. Ogihara Originals Pages: 503 - 508
The ACE-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (BB) rats R. RösenA. F. E. RumpP. Rösen Originals Pages: 509 - 517
In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: Possible relevance to the maladaptive responses to chronic hyperglycaemia A. GiaccariL. MorviducciG. Tamburrano Originals Pages: 518 - 524
Tamm-Horsfall glycoprotein in streptozotocin diabetic rats: a study of kidney in situ hybridization, immunohistochemistry, and urinary excretion R. RaschO. TorffvitN. O. Jacobsen Originals Pages: 525 - 535
Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist K. SakamotoR. KikkawaY. Shigeta Originals Pages: 536 - 542
Rapid deposition of amyloid in human islets transplanted into nude mice P. WestermarkD. L. EizirikA. Andersson Originals Pages: 543 - 549
Incidence of IDDM during 1988–1992 in Zagreb, Croatia G. RoglićI. Pavlić-RenarŽ. Metelko Originals Pages: 550 - 554
Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects T. UtriainenR. MalmströmH. Yki-JÄrvinen Originals Pages: 555 - 564
Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity I. EidemakB. Feldt-RasmussenS. Strandgaard Originals Pages: 565 - 572
Visual evoked potentials in NIDDM: a longitudinal study G. MoreoE. MarianiG. B. Colucci Originals Pages: 573 - 576
Immunogenicity of intraperitoneal insulin infusion using programmable implantable devices N. JeandidierS. BoivinM. Pinget Originals Pages: 577 - 584
Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid artery Y. YamasakiR. KawamoriT. Kamada Originals Pages: 585 - 591
Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen F. S. NielsenL. N. JØrgensenH. -H. Parving Originals Pages: 592 - 598
Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study J. M. StephensonJ. H. FullerThe EURODIAB IDDM Complications Study Group Originals Pages: 599 - 603
Cholesterol-lowering therapy may retard the progression of diabetic nephropathy K. S. L. LamI. K. P. ChengR. W. C. Pang Originals Pages: 604 - 609
Albumin excretion and vascular deaths in NIDDM J. M. MacLeodJ. LutaleS. M. Marshall Originals Pages: 610 - 616
Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance M. LaaksoM. MalkkiS. S. Deeb Originals Pages: 617 - 622
A new marker in the HLA class I region is associated with the age at onset of IDDM A. G. DemaineM. L. HibberdB. A. Millward Originals Pages: 623 - 628
Hypomagnesaemia in childhood IDDM and risk of nephropathy İ. Arslanoğlu Letters to the Editor Pages: 629 - 629
Plasma fibrinogen as cardiovascular risk factor L. BreimerN. ChaturvediJ. -P. Després Letters to the Editor Pages: 630 - 631
Disordered gastric motor function in diabetes mellitus D. P. Mikhailidis Letters to the Editor Pages: 632 - 632
Increased expression of type III and type IV collagen in diabetic nephropathy M. S. Razzaque Letters to the Editor Pages: 632 - 633
Assignment of islet cell antibody titres and selection of subjects for IDDM prevention trials A. De Leiva Letters to the Editor Pages: 633 - 634
